Deferasirox

BreastfeedingGeriatric
  • TRADE NAMES: Exjade (Novartis); Jadenu (Novartis)
  • INDICATIONS: Chronic iron overload due to blood transfusions and in non-transfuson dependent thalassemia syndromes
  • CLASS: Chelator, iron
  • HALF-LIFE: 8–16 hours
RENAL FAILURE, HEPATIC FAILURE, AND GASTROINTESTINAL HEMORRHAGE

See full prescribing information for complete boxed warning.

Our database has 62 adverse reactions for this drug across the following areas

Please login to see the rest of this drug profile


Not a subscriber? Click here to subscribe

SKIN
HAIR
MUCOSAL
CENTRAL NERVOUS SYSTEM
NEUROMUSCULAR/SKELETAL
GASTROINTESTINAL/HEPATIC
RESPIRATORY
ENDOCRINE/METABOLIC
RENAL
HEMATOLOGIC
OTIC
OCULAR
OTHER


Page last updated 12/15/2016

Drug Eruption Mobile Site

Symbol key

Incidence info

  • <1%
  • 1-5%
  • 5-10%
  • 10-15%
  • 15-20%
  • 20-30%
  • >30%

Seriousness info

  • Hospitalization possible
  • Life threatening
  • Fatal

Warnings in other populations info

  • Breast feeding
  • Geriatric
  • Pediatric